For Immediate Release:
|Contact:||Allen & Caron Inc||CLOSURE Medical Corp|
|Joe Allen (investors)||Len Hall (media)||Daniel Pelak, CEO|
|(212) 691-8087||(949) 474-4300||Benny Ward, CFO|
CLOSURE MEDICAL CORP TO PRESENT AT MERRILL LYNCH GLOBAL
PHARMACEUTICAL, BIOTECH & MEDICAL DEVICE CONFERENCE
IN NEW YORK CITY
RALEIGH, NC (January 29, 2003) … CLOSURE Medical Corporation (Nasdaq:CLSR) announced today that it is scheduled to make an investor presentation at the Merrill Lynch Global Pharmaceutical, Biotech & Medical Device Conference on Wednesday, February 5, 2003 at 8:45 a.m. Eastern Time. The conference is being held February 4-6, 2003 at the Grand Hyatt Hotel in New York City.
A live webcast of the Company’s presentation at the Merrill Lynch conference will be available via a link provided under the Investor section of Closure Medical’s website at www.closuremed.com. An archive of the presentation will be available for 14 days.
About CLOSURE Medical Corporation
CLOSURE Medical Corporation is a global leader in the development, manufacture, and commercialization of medical adhesive brands for wound closure and care based on its proprietary medical grade cyanoacrylate technology. CLOSURE’s proprietary technology has customized the physical and chemical properties of cyanoacrylates to develop medical adhesive formulations to close and seal topical skin wounds and incisions.
For additional information on CLOSURE Medical visit its website at www.closuremed.com or visit the “Clients” section of the Allen & Caron website at www.allencaron.com.